Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of topotecan in treating children who have
recurrent, relapsed, or refractory sarcoma. Drugs used in chemotherapy use different ways to
stop tumor cells from dividing so they stop growing or die.